BRIGHT MINDS BIOSCIENCES INC. (DRUG) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: December 23, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 64.1% (2 years)

Historical Dilution Factor: significant recent dilution

Outstanding Shares

7.6M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

DRUG currently has 7.64M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 64.1% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Dec 23, 2025	40-F filing \| 7.6M shares outstanding	7.6M
Feb 05, 2025	F-3 filing: Resale of up to 1,612,902 common shares by selling securityholders, originally issued in a private placement on November 4, 2024.	7M
Dec 31, 2024	20-F filing \| 4.5M shares outstanding	4.5M
Dec 29, 2023	20-F filing \| 4.5M shares outstanding	4.5M
Dec 29, 2022	20-F filing \| 17.6M shares outstanding	18M
Dec 29, 2021	20-F filing \| 11.8M shares outstanding	12M

Back to DRUG Details